Oncolytics Biotech
ONCY
35 hedge funds and large institutions have $1.56M invested in Oncolytics Biotech in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 5 closing their positions.
91% more capital invested
Capital invested by funds: $818K → $1.56M (+$741K)
67% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 6
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
6% more funds holding
Funds holding: 33 → 35 (+2)
0.52% more ownership
Funds ownership: 1.6% → 2.11% (+0.52%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$192K |
| 2 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$82.2K |
| 3 |
FC
Financial Consulate
Hunt Valley,
Maryland
|
+$78.1K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$71.6K |
| 5 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
+$34.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
-$66K |
| 2 |
Renaissance Technologies
New York
|
-$58K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$13.2K |
| 4 |
Two Sigma Advisers
New York
|
-$8.66K |
| 5 |
PFGIA
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $6K | – | – | – |
|
27
Bank of America
Charlotte,
North Carolina
| $4K | +$1.75K | +927 | +107% |
|
28
Fifth Third Bancorp
Cincinnati,
Ohio
| $2K | – | – | – |
|
29
Rockefeller Capital Management
New York
| $1K | -$198 | -105 | -16% |
|
30
1832 Asset Management
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
31
Bank Julius Baer & Co
Zurich,
Switzerland
| $1K | +$60 | +32 | +4% |
|
|
TI
32
tru Independence
Portland,
Oregon
| $7 | – | – | – |
|
|
SC
33
Scotia Capital
Toronto,
Ontario, Canada
| – | -$66K | -47,227 | Closed |
|
|
34
Renaissance Technologies
New York
| – | -$58K | -41,999 | Closed |
|
|
PFGIA
35
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
| – | -$6K | -4,000 | Closed |
|
|
NFG
36
Next Financial Group
Houston,
Texas
| – | -$2K | -1,472 | Closed |
|
37
UBS Group
Zurich,
Switzerland
| – | -$1.09K | -580 | -78% |
|
|
CPA
38
Cowen Prime Advisors
New York
| – | -$1K | -500 | Closed |
|
ONCY Hedge Fund Activity: Q2 2020 in Review
35 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Oncolytics Biotech (ONCY) for Q2 2020, worth a combined $1.56M — up 91% from $818K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ONCY positions and 5 closed out — a net gain of 2 holders — while 10 added to existing stakes and 6 trimmed.
The largest buyer was Wedbush Securities, adding an estimated $192K. The largest seller was Scotia Capital, exiting entirely with an estimated $66K sold.
- 35 institutional investors held Oncolytics Biotech (ONCY) as of Q2 2020, up from 33 in Q1 2020.
- Funds reported $1.56M of Oncolytics Biotech stock for Q2 2020, up 91% quarter-over-quarter.
- 7 funds opened new Oncolytics Biotech positions in Q2 2020 and 5 closed out, a net change of +2 holders.
- The largest Oncolytics Biotech buyer in Q2 2020 was Wedbush Securities, an estimated $192K added.
- The largest Oncolytics Biotech seller in Q2 2020 was Scotia Capital, an estimated $66K sold.
Based on aggregated 13F filings for Q2 2020.